ASPHALION is a Regulatory & Scientific Consulting in Life Sciences with offices in Barcelona, Madrid, Munich and London. Founded in 2000, ASPHALION has grown consistently and currently employs over 150 team members of over 16 different nationalities.
Its strong track record has made ASPHALION a reference in the international healthcare sector and a key stakeholder in the implementation of new regulatory standards. ASPHALION’s experts have delivered solutions to over 1,000 Pharmaceutical, Biotechnological and Medical Technology companies from more than 50 countries in over 5,000 projects covering non-clinical and clinical development, CMC, dossier writing, regulatory procedures, vigilance, eSubmissions and data management for both medicinal products and medical devices. Asphalion has already experience as regulatory expert working in vaccine developments, collaborating with biotech and pharma companies from preclinical phases to clinical and marketing authorization applications.
ASPHALION offers strategic advice, expert consulting, operational support, as well as full outsourcing services for vaccine developments in all therapeutic areas including, for instance, COVID-19 vaccine development or HIV therapeutic vaccines. To deliver the best possible solution in each project, ASPHALION works closely with international competent authorities, notified bodies, scientific associations and key opinion leaders and maintains a comprehensive network of geographic and functional partners.